ID   NCC-pRMS1-X4-C1
AC   CVCL_B3TN
SY   NCCPRMS1X4C1
DR   DepMap; ACH-002788
DR   Wikidata; Q110433089
RX   DOI=10.11418/jtca.38.1;
WW   https://en.cellline.jp/product/ncc-prms1-x4-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a fourth generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 40 hours (DOI=10.11418/jtca.38.1).
CC   Derived from site: In situ; Right thigh, muscle; UBERON=UBERON_0004252.
ST   Source(s): DOI=10.11418/jtca.38.1
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 28,32.2
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C4258; Pleomorphic rhabdomyosarcoma
DI   ORDO; Orphanet_293199; Pleomorphic rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TM ! NCC-pRMS1-C1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
RX   DOI=10.11418/jtca.38.1;
RA   Oyama R., Takahashi M., Kito F., Sakumoto M., Takai Y., Shiozawa K.,
RA   Qiao Z.-W., Toki S., Tanzawa Y., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of patient-derived pleomorphic
RT   rhabdomyosarcoma models.";
RL   Tissue Cult. Res. Commun. 38:1-12(2019).
//